Grant Gordon and other administration members are simply trying to distract the shareholders that Cardiovascular Biotherapeutics/Venturis Therapeutics has zero value whatsoever. As the lawyer said so clearly in US Federal Court records: CVBT/VT has no assets and no revenue stream.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.